ANT‐DBS in epilepsy shows no effect on selected neuropsychiatric tests

OBJECTIVES: Deep brain stimulation of the anterior thalamic nucleus (ANT‐DBS) is an established option in treatment‐resistant epilepsy and obtained FDA approval in 2018. Increased psychiatric comorbidity is well known in epilepsy. The main objective of this study was to investigate possible neuropsy...

Descripción completa

Detalles Bibliográficos
Autores principales: Herrman, Helle, Osnes, Kåre, Egge, Arild, Konglund, Ane, Ramm‐Pettersen, Jon, Dietrichs, Espen, Taubøll, Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545573/
https://www.ncbi.nlm.nih.gov/pubmed/35649713
http://dx.doi.org/10.1111/ane.13658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545573/
https://www.ncbi.nlm.nih.gov/pubmed/35649713
http://dx.doi.org/10.1111/ane.13658

Ejemplares similares